SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

VYGRSell

Voyager Therapeutics, Inc.

Alfred Sandrock · President and CEO

$45K−2.0%Apr 3
VYGRSell

Voyager Therapeutics, Inc.

Alfred Sandrock · President and CEO

$54K−3.0%Feb 26
VYGRSell

Voyager Therapeutics, Inc.

Alfred Sandrock · President and CEO

$40K−2.0%Feb 20
VYGRSell

Voyager Therapeutics, Inc.

Alfred Sandrock · President and CEO

$46K−2.0%Feb 11
VYGRSell

Voyager Therapeutics, Inc.

Sandell Jacquelyn Fahey · General Counsel

$35K−7.0%Oct 3
VYGRSell

Voyager Therapeutics, Inc.

Alfred Sandrock · President and CEO

$119K−4.0%Apr 3
VYGRSell

Voyager Therapeutics, Inc.

Alfred Sandrock · President and CEO

$97K−4.0%Feb 22
VYGRSell

Voyager Therapeutics, Inc.

Robin Swartz · COO

$30K−3.0%Feb 22
VYGRSell

Voyager Therapeutics, Inc.

Peter P. Pfreundschuh · CFO

$28K−2.0%Feb 22
VYGRSell

Voyager Therapeutics, Inc.

Todd Alfred Carter · Chief Scientific Officer

$30K−4.0%Feb 22
VYGRSell

Voyager Therapeutics, Inc.

Peter P. Pfreundschuh · CFO

$95K−8.0%Oct 5
VYGRSell

Voyager Therapeutics, Inc.

Todd Alfred Carter · Chief Scientific Officer

$86K−16.0%Sep 18
VYGRSell

Voyager Therapeutics, Inc.

Todd Alfred Carter · Chief Scientific Officer

$59K−8.0%Jul 10
VYGRSell

Voyager Therapeutics, Inc.

Todd Alfred Carter · Chief Scientific Officer

$57K−7.0%Jul 5
VYGRSell

Voyager Therapeutics, Inc.

Alfred Sandrock · President and CEO

$58K−3.0%Apr 5
VYGRSell

Voyager Therapeutics, Inc.

Robin Swartz · COO

$28K−5.0%Mar 22
VYGRSell

Voyager Therapeutics, Inc.

Robert W. Hesslein · SVP and General Counsel

$34K−4.0%Mar 22
VYGRSell

Voyager Therapeutics, Inc.

Robin Swartz · COO

$126K−17.0%Mar 17
VYGRBuy

Voyager Therapeutics, Inc.

Neurocrine Biosciences Inc · 10% owner

$39.0M+105.0%Feb 24
VYGRSell

Voyager Therapeutics, Inc.

Third Rock Ventures Iii, L.P. · 10% owner

$3.6M−8.0%Feb 1
VYGRSell

Voyager Therapeutics, Inc.

Third Rock Ventures Iii, L.P. · 10% owner

$451K−1.0%Jan 31
VYGRSell

Voyager Therapeutics, Inc.

Third Rock Ventures Iii, L.P. · 10% owner

$1.4M−3.0%Jan 26
VYGRSell

Voyager Therapeutics, Inc.

Third Rock Ventures Iii, L.P. · 10% owner

$1.4M−3.0%Jan 24
VYGRSell

Voyager Therapeutics, Inc.

Ecor1 Capital, LLC · 10% owner

$7.1M−19.0%Jan 11
VYGRSell

Voyager Therapeutics, Inc.

Third Rock Ventures Iii, L.P. · 10% owner

$2.2M−6.0%Aug 26
VYGRSell

Voyager Therapeutics, Inc.

Third Rock Ventures Iii, L.P. · 10% owner

$776K−2.0%Aug 18
VYGRSell

Voyager Therapeutics, Inc.

Third Rock Ventures Iii, L.P. · 10% owner

$3.0M−8.0%Aug 16
VYGRSell

Voyager Therapeutics, Inc.

Glenn Pierce · Director

$64K−30.0%Jul 18
VYGRSell

Voyager Therapeutics, Inc.

Michael J Higgins · Director

$93K−31.0%Jul 18
VYGRSell

Voyager Therapeutics, Inc.

Robin Swartz · COO

$37K−8.0%Mar 23
VYGRSell

Voyager Therapeutics, Inc.

Robert W. Hesslein · SVP and General Counsel

$41K−4.0%Mar 23
VYGRSell

Voyager Therapeutics, Inc.

Andre Turenne · President and CEO

$60K−5.0%Feb 16
VYGRSell

Voyager Therapeutics, Inc.

Omar Khwaja · Insider

$26K−6.0%Feb 16
VYGRSell

Voyager Therapeutics, Inc.

Andre Turenne · President and CEO

$90K−6.0%Jan 14
VYGRSell

Voyager Therapeutics, Inc.

Allison Dorval · CFO

$25K−6.0%Jan 14
VYGRSell

Voyager Therapeutics, Inc.

Omar Khwaja · Insider

$45K−6.0%May 22
VYGRSell

Voyager Therapeutics, Inc.

Robert W. Hesslein · SVP and General Counsel

$26K−6.0%Apr 7
VYGRSell

Voyager Therapeutics, Inc.

Allison Dorval · CFO

$42K−11.0%Jan 29
VYGRSell

Voyager Therapeutics, Inc.

Matthew P. Ottmer · COO

$50K−12.0%Jan 29
VYGRSell

Voyager Therapeutics, Inc.

Andre Turenne · President and CEO

$143K−11.0%Jan 29
VYGRBuy

Voyager Therapeutics, Inc.

Neurocrine Biosciences Inc · 10% owner

$50.0MMar 14
VYGRBuy

Voyager Therapeutics, Inc.

James A Geraghty · Director

$58K+4.0%Sep 12
VYGRBuy

Voyager Therapeutics, Inc.

Glenn Pierce · Director

$92KSep 12
VYGRBuy

Voyager Therapeutics, Inc.

James A Geraghty · Director

$55K+4.0%Aug 21
VYGRSell

Voyager Therapeutics, Inc.

Bernard Ravina · Chief Medical Officer

$45K−100.0%Apr 12
VYGRSell

Voyager Therapeutics, Inc.

Jane Henderson · SVP, CFO, Corp. Dev.

$649K−100.0%Mar 26
VYGRSell

Voyager Therapeutics, Inc.

Jane Henderson · CFO, SVP, Corp. Dev.

$383K−100.0%Mar 20
VYGRSell

Voyager Therapeutics, Inc.

Bernard Ravina · Chief Medical Officer

$62K−50.0%Mar 14
VYGRSell

Voyager Therapeutics, Inc.

Dinah Ph.d. Sah · Chief Scientific Officer

$469K−10.0%Mar 1
VYGRSell

Voyager Therapeutics, Inc.

Bernard Ravina · Chief Medical Officer

$45K−33.0%Feb 13

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.